ASX Announcement - FY26 Full Year Results
Filed with ASX · · 3 pages · English
Summary by 6ix AI
The company reported a positive EBITDA and net profit after tax, despite some challenges affecting gross margin and net profit compared to the prior period. Regional performance showed growth across all areas, particularly in the Asia-Pacific region, contributing to overall sales increases. The CEO emphasized the company's strategic focus on expanding its core wound care franchise and enhancing the NovoSorb platform for future growth opportunities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Polynovo
- PolyNovo FY26 Trading Update
- Response to ASX Price Query
- Appendix 4D & H1 FY26 Financial Statements
- 1H FY26 Results Presentation
- 1H26 Trading Result (unaudited)
Later from Polynovo
All Polynovo news releasesFollow Polynovo into a list and get an email when it puts out news.
Follow Polynovo